Events and Conferences

Contact Veristat Now


Request A Proposal

Contact Us

Webinar | Strategies for Solving the Challenges of an Extraordinary Natural History Study

May 16, 2022

Navigating the Patient Experience When Pivoting to a Virtual Model Mid-Study

 

Read More

Webinar | Expediting Access to Novel/Medicinal Products in the US and EU

March 25, 2022

Regulatory Pathways Available to Speed Development and Approval

Read More

Webinar on Medical Devices Software

January 26, 2022

Veristat (formerly DDR) and partner CN Group co-organized an informative session on the development and Regulation of Medical Device Software (MDSW). The live webinar was held on 14 October 2021 and covered the main considerations to keep in mind when developing a MDSW under the new Medical Devices Regulation (MDR). 

Read More

On-Demand Webinar | What is the Future Landscape of Cell and Gene Therapies?

August 11, 2021

The Potential for New Efficiencies to Allow for Scalability in Cell and Gene Therapy Clinical Development

Read More

On-Demand Webinar| Expanding your Clinical Trial into the US - Submit your IND for non-US Sponsors

May 20, 2021

How, why, and when to expand your clinical trial program into the US, including differences between IND and CTA 

Read More

On-Demand Webinar | What's New in Draft MHPD Guidance on Reporting Adverse Reactions for Marketed Products

April 12, 2021

Certus PV, a Veristat Company experts recently lead an Xtalks webinar - View it On-Demand Now

Read More

On-Demand Webinar | How to Better Plan Your Decentralized/Virtual Clinical Trial

March 2, 2021

Veristat experts recently led an Xtalks webinar on lessons learned for planning decentralized clinical trials.

Read More

Webinar | Roadmap to Market for Cell and Gene Therapies

October 12, 2020

View the On-Demand Webinar

VIEW WEBINAR

Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.

 

Read More